Stockhead on MSN

Lunch Wrap: ASX shrugs off global jitters as Coles gets a clip

The ASX is holding steady near record highs on Friday, as earnings season drive sharp moves across the board. ... Read More ...
pharmaphorum

Beam launches $500m financing on base-editing trial data

Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...